| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biocardia, Inc. (BCDA) has 9 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. BCDA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 293.3K | $283.5K | - | |
| CFO | 106.2K | $102.7K | - | |
| VP | 47.0K | $45.5K | - | |
| Dir | 15.7K | $15.2K | - | |
| Dir | 15.6K | $15.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2025 | Altman Peter47 | President And CEO | Buy | 700 | $1.83 | $1,281.00 | +0.4% | -33.0% | - | |
| Aug 13, 2025 | Altman Peter47 | President And CEO | Buy | 100 | $1.83 | $183.00 | - | -28.5% | - | |
| Aug 12, 2025 | Altman Peter47 | President And CEO | Buy | 400 | $1.75 | $700.40 | +0.2% | -25.9% | - | |
| Aug 11, 2025 | Altman Peter47 | President And CEO | Buy | 1,700 | $1.76 | $2,988.60 | +1.0% | -23.2% | - | |
| Jun 30, 2025 | McClung David | Chief Financial Officer | Buy | 4,819 | $2.08 | $9,999.43 | +11.2% | -28.2% | - | |
| Jun 30, 2025 | Altman Peter47 | President And CEO | Buy | 24,096 | $2.08 | $49,999.20 | +17.0% | -28.2% | - | |
| Jun 30, 2025 | Blank Andrew Scott | Director | Buy | 72,289 | $2.08 | $149,999.68 | +26.4% | -28.2% | - | |
| Jun 30, 2025 | Stertzer Simon H | Director | Buy | 72,289 | $2.08 | $149,999.68 | +60.1% | -28.2% | - | |
| May 30, 2025 | Altman Peter47 | President And CEO | Buy | 100 | $2.21 | $221.00 | - | -9.3% | -56.9% | |
| May 22, 2025 | Altman Peter47 | President And CEO | Buy | 2,300 | $2.02 | $4,651.00 | +0.8% | -3.7% | -49.5% |